Insulin Under the BPCIA: Opportunities and Obstacles
April 22, 2020
Ted Mathias and Stacie Ropka, PhD
Biosimilar Development
Axinn partners Ted Mathias and Stacie Ropka authored the Biosimilar Development article, "Insulin Under the BPCIA: Opportunities and Obstacles."
Click here to access the article.